Inactive Instrument
Cellivery Therapeutics, Inc. Share Price
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 4L | |
| -3.00% | +0.33% | +77.39% | +109.41% | 7.4TCr | |
| +1.90% | +19.57% | +60.16% | +101.03% | 6.47TCr | |
| +0.55% | -0.44% | -2.84% | +478.79% | 2.73TCr | |
| +5.12% | +26.54% | +4.73% | +5.63% | 2.79TCr | |
| +2.74% | +11.55% | +66.56% | +27.34% | 2.6TCr | |
| +0.47% | +6.22% | +39.36% | -12.38% | 2TCr | |
| +1.82% | -3.11% | +245.72% | +423.83% | 1.78TCr | |
| +0.94% | +2.38% | +24.83% | +552.12% | 1.62TCr | |
| +0.73% | +6.86% | +42.84% | +156.30% | 1.33TCr | |
| Average | -1.92% | +6.16% | +62.08% | +204.67% | 3.19TCr | |
| Weighted average by Cap. | +0.68% | +6.66% | +61.09% | +163.45% |
Employees
-
